Intuitive Surgical, Inc. $ISRG Stock Position Raised by Valley Wealth Managers Inc.

Valley Wealth Managers Inc. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 52.7% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 4,084 shares of the medical equipment provider’s stock after purchasing an additional 1,409 shares during the period. Valley Wealth Managers Inc.’s holdings in Intuitive Surgical were worth $1,826,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. SteelPeak Wealth LLC increased its position in Intuitive Surgical by 28.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after buying an additional 9,364 shares during the period. Amalgamated Bank boosted its position in shares of Intuitive Surgical by 2.2% in the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after acquiring an additional 1,772 shares during the period. Bessemer Group Inc. grew its stake in shares of Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after acquiring an additional 371,806 shares during the last quarter. Sax Wealth Advisors LLC increased its position in Intuitive Surgical by 218.1% during the second quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock worth $1,334,000 after acquiring an additional 1,684 shares during the period. Finally, World Investment Advisors raised its stake in Intuitive Surgical by 238.3% during the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock valued at $2,415,000 after purchasing an additional 3,803 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ISRG. Evercore ISI decreased their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research report on Friday, January 23rd. The Goldman Sachs Group reiterated a “buy” rating and issued a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. Jefferies Financial Group boosted their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. Wells Fargo & Company raised their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Finally, Barclays set a $712.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $620.41.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 464 shares of the stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36. Following the completion of the sale, the senior vice president owned 131 shares in the company, valued at $71,852.19. This trade represents a 77.98% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares of the company’s stock, valued at $1,958,189.40. This represents a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 75,683 shares of company stock worth $42,066,425 in the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Down 0.7%

Shares of ISRG opened at $504.22 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The stock has a 50 day simple moving average of $558.64 and a 200-day simple moving average of $511.63. The stock has a market cap of $180.75 billion, a PE ratio of 63.91, a PEG ratio of 3.92 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.